‘MAHA’ is moving into Trump’s White House. Here’s who RFK Jr. could bring along for the ride

WASHINGTON — MAGA, meet MAHA.

The sweeping election victory for President-elect Donald Trump this week also marks the start of an ambitious anti-chronic disease campaign, “Make America Healthy Again,” that has become central to Trump’s health agenda.

The leading MAHA man is Robert F. Kennedy Jr., the lawyer, environmentalist and anti-vaccine advocate whom Trump has vowed to unleash upon federal health care agencies in his next term. Among Kennedy’s list of policy proposals are banning direct-to-consumer pharmaceutical advertising, cracking down on ultra-processed foods, and rooting out scientists and health advisers with ties to the food and pharmaceutical industries.

STAT+ Exclusive Story

This article is exclusive to STAT+ subscribers

Unlock this article — plus in-depth analysis, newsletters, premium events, and news alerts.

Already have an account? Log in

View All Plans

To read the rest of this story subscribe to STAT+.

House panel passes public health bills following contentious debate

WASHINGTON — The House Energy and Commerce health subcommittee on Thursday voted along party lines to pass a bill to let employers provide telehealth-only insurance

July 13, 2023

New Long COVID Definition Proposed by National Academies

A new report from the National Academies of Sciences, Engineering, and Medicine (NASEM) offers a new definition of long COVID in an effort to streamline

June 12, 2024

Adjuvant anthracycline- plus taxane-based chemotherapy regimen improves survival in high-risk breast cancer patients

Patients with early-stage, node-negative, hormone receptor (HR)-positive, HER2- negative breast cancer who have a high risk of recurrence based on the OncotypeDX genomic test had

December 14, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.